Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis

Figure 1

K trans maps from a patient with liver metastases treated with nintedanib 250 mg once-daily (#18). Maps were registered to original TrueFISP images taken (a) pretreatment, (b) on day 2 and (c) on day 28. Abbreviation: Ktrans = volume transfer constant between blood plasma and extravascular extracellular space.

Back to article page